Who owns BioCryst Pharmaceuticals Inc (BCRX)? Superinvestor holders

2 superinvestors of the 157 tracked here hold BioCryst Pharmaceuticals Inc (BCRX) in their latest 13F filing, with $166.8M between them. Peter Kolchinsky gives it the most weight: 1.38% of the reported portfolio. In their latest reported quarter, Louis Bacon added.

Hold it now
2
of 157 tracked
Combined value
$166.8M
Bought / sold
1 / 0
last quarter

Key facts

Superinvestors holding it
2 of 157
Biggest holder
Peter Kolchinsky, $158.3M
Largest weight
Peter Kolchinsky, 1.38%of their portfolio
Combined value
$166.8M
Bought last quarter
1
Sold last quarter
0

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding BCRX, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Peter KolchinskyRA Capital Management1.38%$158.3M15.83MNo change0Q2 2026
2Louis BaconMoore Capital Management0.24%$8.5M1.02M▲ Added 20%+173.56KQ3 2026

Quarter by quarter

Superinvestor ownership of BCRX by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269211.02M$8.5M10
Q2 2026157216.68M$166.8M10
Q1 2026157215.85M$150.9M01
Q4 2025157318.67M$145.7M21
Q3 202515725.49M$41.7M11
Q2 202515715.71M$51.2M01
Q1 202515617.21M$54.1M10
Q4 202415617.09M$53.3M01

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of BCRX held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Louis Bacon1.02M848.34K——————
Peter Kolchinsky·15.83M15.83M15.83M————
Andrew Spokes——24K24K24K———
Julian and Felix Baker·——2.82M————
Takis Sparaggis————5.46M5.71M7.21M7.09M

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own BCRX?

In their latest 13F filings: Peter Kolchinsky (1.38% of the portfolio, $158.3M), Louis Bacon (0.24% of the portfolio, $8.5M).

Who bought BCRX last quarter?

Louis Bacon (added 20%). “Last quarter” is each investor's latest reported quarter.

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns BioCryst Pharmaceuticals Inc (BCRX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/BCRX/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to BCRX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.